第3天单胚胎移植联合时差成像选择与第5天单胚胎移植联合或不联合时差成像选择的先导性随机对照试验
该先导性随机对照试验纳入163例患者,比较第3天单胚胎移植联合Eeva™时差成像选择、第5天单胚胎移植联合Eeva™时差成像选择与第5天单胚胎移植仅用常规形态学选择对每移植临床妊娠率的影响。结果显示三组间临床妊娠率和持续妊娠率均无统计学显著差异,证据不足以得出联合时差成像选择可提高临床妊娠率的结论。
要点
- 三组每移植临床妊娠率(意向性分析)分别为第3天+Eeva™ 41.1%、第5天+Eeva™ 38.9%、第5天常规形态学 49.1%,无统计学显著差异。
- 意向性分析和按实际治疗分析中,临床妊娠率与持续妊娠率在三组间均无统计学显著差异。
- 作者认为 findings 不支持这些时差成像标志物的临床应用。
核心结论
- 证据不足以得出第3天或第5天联合使用Eeva™时差成像选择较第5天常规形态学选择能提高每移植临床妊娠率的结论。
- 作者认为研究结果不支持这些时差成像标志物的临床应用。
研究设计与样本
- 先导性随机对照试验,2014年8月至2016年2月纳入163例患者。
- 纳入年龄不超过41岁、计划行新鲜自体单胚胎移植、既往取卵次数少于4次且合子数4个或以上的患者。
- 按年龄(<35岁、35-37岁、38-40岁)分层随机分为三组:第3天单胚胎移植+Eeva™、第5天单胚胎移植+Eeva™、第5天单胚胎移植仅用常规形态学选择。
- 所有胚胎均在相同条件下同一时差成像系统中培养。
- 主要终点为7周时临床妊娠率,次要终点为12周时持续妊娠率,行意向性治疗和按实际治疗分析,多因素回归校正患者年龄和ICSI。
主要发现
- 478例合格患者中217例同意、163例被随机分组,三组人口学特征相似。
- 意向性治疗分析中,临床妊娠率第3天+Eeva™组41.1% vs 第5天+Eeva™组38.9% vs 第5天常规形态学组49.1%,三组间无统计学显著差异。
- 意向性治疗和按实际治疗分析中,临床妊娠率和持续妊娠率在三组间均无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
- 作者认为研究结果不支持这些时差成像标志物的临床应用。
局限性
- 本研究设计为先导性随机对照试验,未以α<0.05检测统计学显著差异为效能目标。
- 研究因申办方资金优先方向改变而提前终止,样本量有限,结果因偶然作用应谨慎解读。
- 研究结果可能不能推广至其他时差成像系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Compared to D5 selection with conventional morphology (CM), does adjunctive use of the Eeva™ test on D3 or D5 improve the clinical pregnancy rate (CPR) per transfer? SUMMARY ANSWER: The evidence is insufficient to conclude that adjunctive use of the Eeva™ test on D3 or D5 improves CPR per transfer as compared to D5 selection with CM. WHAT IS KNOWN ALREADY: Time-lapse imaging is increasingly used for embryo selection, despite there being no class I data to support its clinical application. STUDY DESIGN, SIZE, DURATION: Pilot randomized controlled trial included 163 patients from August 2014 to February 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients up to age 41 years with a planned fresh autologous single embryo transfer (SET), less than four prior oocyte retrievals, and four or more zygotes were blocked according to age (<35, 35-37, 38-40 years) and randomized to one of three study arms: (1) D3 SET + EevaTM, (2) D5 SET + Eeva™ or (3) D5 SET with CM alone. All embryos were cultured in the same time-lapse system under identical conditions. Intention-to-treat (ITT) and as-treated analyses of the primary endpoint (CPR at 7 weeks) and secondary endpoint (ongoing pregnancy rate at 12 weeks) were performed. Multivariate regression analyses adjusted for patient age and ICSI. MAIN RESULTS AND THE ROLE OF CHANCE: Of 478 eligible patients, 217 consented and 163 were randomized. Demographic characteristics were similar among the three study arms. There were no statistically significant differences in the clinical pregnancy rate or the ongoing pregnancy rate between the study arms for either the ITT or as-treated analyses (CPR ITT: D3 + Eeva™: 41.1% vs. D5 + Eeva™: 38.9% vs. D5 CM: 49.1%). LIMITATIONS, REASONS FOR CAUTION: This study was designed as a pilot randomized controlled trial and was not powered to detect a statistically significant difference at α < 0.05. Importantly, the study was terminated prematurely by the sponsor due to a change in funding priorities, so the sample size is limited and the results should be interpreted with caution due to the role of chance. Furthermore, these findings may not be generalizable to other time-lapse systems. WIDER IMPLICATIONS OF THE FINDINGS: Our findings do not support the clinical application of these time-lapse markers. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by Progyny, Inc. There are no competing interests. TRIAL REGISTRATION NUMBER: clinicaltrials.gov: NCT02218255. TRIAL REGISTRATION DATE: 14 August 2014. DATE OF FIRST PATIENT'S ENROLLMENT: 3 September 2014.
引用
- Kaser DJ, Bormann CL, Missmer SA, et al. A pilot randomized controlled trial of Day 3 single embryo transfer with adjunctive time-lapse selection versus Day 5 single embryo transfer with or without adjunctive time-lapse selection. Hum Reprod. 2017. PMID: 28854588. doi:10.1093/humrep/dex231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。